J 2015

Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care

HJORTH, Lars, Riccardo HAUPT, Roderick SKINNER, Desiree GRABOW, Julianne BYRNE et. al.

Základní údaje

Originální název

Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care

Autoři

HJORTH, Lars (752 Švédsko), Riccardo HAUPT (380 Itálie), Roderick SKINNER (826 Velká Británie a Severní Irsko), Desiree GRABOW (276 Německo), Julianne BYRNE (372 Irsko), Sabine KARNER (40 Rakousko), Gill LEVITT (826 Velká Británie a Severní Irsko), Gisela MICHEL (756 Švýcarsko), Helena van der PAL (528 Nizozemské království), Edit BARDI (348 Maďarsko), Jörn D. BECK (276 Německo), Florent de VATHAIRE (250 Francie), Stefan ESSIG (756 Švýcarsko), Eva FREY (40 Rakousko), Stanislav GARWICZ (752 Švédsko), Mike HAWKINS (826 Velká Británie a Severní Irsko), Zsuzsanna JAKAB (348 Maďarsko), Momcilo JANKOVIC (380 Itálie), Bernarda KAZANOWSKA (616 Polsko), Tomáš KEPÁK (203 Česká republika, garant, domácí), Leontinen KREMER (528 Nizozemské království), Herwig LACKNER (40 Rakousko), Elaine SUGDEN (826 Velká Británie a Severní Irsko), Monica TERENZIANI (380 Itálie), Lorna Zadravec ZALETEL (705 Slovinsko) a Peter KAATSCH (276 Německo)

Vydání

European Journal of Cancer, Oxford, Elsevier Science Inc. 2015, 0959-8049

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 6.163

Kód RIV

RIV/00216224:14110/15:00083602

Organizační jednotka

Lékařská fakulta

UT WoS

000355332000001

Klíčová slova anglicky

Childhood cancer; Survivorship; Long-term care; Long-term follow-up; Late effects

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 8. 2015 14:41, Soňa Böhmová

Anotace

V originále

Survival after childhood cancer has improved substantially over recent decades. Although cancer in childhood is rare increasingly effective treatments have led to a growing number of long-term survivors. It is estimated that there are between 300,000 and 500,000 childhood cancer survivors in Europe. Such good survival prospects raise important questions relating to late effects of treatment for cancer. Research has shown that the majority will suffer adverse health outcomes and premature mortality compared with the general population. While chronic health conditions are common among childhood cancer survivors, each specific type of late effect is very rare. Long-term effects must be considered particularly when addressing complex multimodality treatments, and taking into account the interaction between aspects of treatment and genotype. The PanCare Network was set up across Europe in order to effectively answer many of these questions and thereby improve the care and quality of life of survivors. The need for a structured long-term follow-up system after childhood cancer has been recognised for some time and strategies for implementation have been developed, first nationally and then trans-nationally, across Europe. Since its first meeting in Lund in 2008, the goal of the PanCare Network has been to coordinate and implement these strategies to ensure that every European survivor of childhood and adolescent cancer receives optimal long-term care. This paper will outline the structure and work of the PanCare Network, including the results of several European surveys, the start of two EU-funded projects and interactions with relevant stakeholders and related projects.